Correlation Between SAB Biotherapeutics and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and ANI Pharmaceuticals, you can compare the effects of market volatilities on SAB Biotherapeutics and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and ANI Pharmaceuticals.
Diversification Opportunities for SAB Biotherapeutics and ANI Pharmaceuticals
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and ANI is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and ANI Pharmaceuticals
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 11.17 times more return on investment than ANI Pharmaceuticals. However, SAB Biotherapeutics is 11.17 times more volatile than ANI Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 5.00 in SAB Biotherapeutics on August 27, 2024 and sell it today you would earn a total of 2.30 from holding SAB Biotherapeutics or generate 46.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 85.71% |
| Values | Daily Returns |
SAB Biotherapeutics vs. ANI Pharmaceuticals
Performance |
| Timeline |
| SAB Biotherapeutics |
| ANI Pharmaceuticals |
SAB Biotherapeutics and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and ANI Pharmaceuticals
The main advantage of trading using opposite SAB Biotherapeutics and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |